Tujoromajo Kasuto
THE German Federal Government has lifted all entry restrictions for residents of Namibia with effect from Tuesday, 2 November 2021 at midnight and the country has been placed on the German “positive list”.
The German embassy further informs that travel to Germany by Namibian residents is therefore again permitted for all travel purposes from this date. For people older than 12 years, proof of a negative test, recovery or vaccination is required upon entry.
This June Germany listed Namibia as Covid-19 high risk area and the country was only removed from the list in September.
Meanwhile, the Ministry of Health and Social Services (MoHSS) has announced it conducting free testing for students going to study abroad.
The ministry says it will continue to offer assistance to Namibian students studying abroad by exempting them from paying for Covid-19 tests at any of the authorised Covid-19 testing laboratories in the country.
This is done on their departure to study abroad, provided adequate proof has been submitted by the student and this will be effective as from the 6th of November. However, students will only be tested twice a year at the Government’s expense. The change to student Covid-19 test exemption permit provided by the MoHSS was brought about by the fact that some students were requesting for this service with frequent regularity.
Mandatory documentation required include two certified copies of a valid passport, two certified copies of a proof of registration or confirmation letter from the university for the year that is being attended. In addition, two certified copies of a valid study permit and two certified copies of student card.
The ministry says the mandatory documents should be taken to the MoHSS Head Office, Harvey Street, and old NMRC building. The telephone contact number is: 061 203 2334.
Meantime the country currently has a cumulative confirmed Covid-19 cases of 128 956, with a 97 percent recovery rate and 734 active cases. The cumulative number of the fully vaccinated stands at 264544 with 331648 having received their first dose.
